Literature DB >> 32696038

The Registry of Senior Australians outcome monitoring system: quality and safety indicators for residential aged care.

Maria C Inacio1,2, Catherine Lang1, Gillian E Caughey1,2, Sarah C E Bray1, Stephanie L Harrison1,3, Craig Whitehead4,5, Renuka Visvanathan6,7, Keith Evans1, Megan Corlis8, Victoria Cornell9, Steve Wesselingh10.   

Abstract

OBJECTIVES: To introduce the Registry of Senior Australians (ROSA) Outcome Monitoring System, which can monitor the quality and safety of care provided to individuals accessing residential aged care. Development and examination of 12 quality and safety indicators of care and their 2016 prevalence estimates are presented.
DESIGN: Retrospective.
SETTING: 2690 national and 254 South Australian (SA) aged care facilities. PARTICIPANTS: 208 355 unique residents nationally and 18 956 in SA. MAIN OUTCOME MEASURES: Risk-adjusted prevalence of high sedative load, antipsychotic use, chronic opioid use, antibiotic use, premature mortality, falls, fractures, medication-related adverse events, weight loss/malnutrition, delirium and/or dementia hospitalisations, emergency department presentations, and pressure injuries.
RESULTS: Five indicators were estimated nationally; antibiotic use (67.5%, 95% confidence interval (CI): 67.3-67.7%) had the highest prevalence, followed by high sedative load (48.1%, 95% CI: 47.9-48.3%), chronic opioid use (26.8%, 95% CI: 26.6-26.9%), antipsychotic use (23.5%, 95% CI: 23.4-23.7%) and premature mortality (0.6%, 95% CI: 0.6-0.7%). Seven indicators were estimated in SA; emergency department presentations (19.1%, 95% CI: 18.3-20.0%) had the highest prevalence, followed by falls (10.1%, 95% CI: 9.7-10.4%), fractures (4.8%, 95% CI: 4.6-5.1%), pressure injuries (2.9%, 95% CI: 2.7-3.1%), delirium and/or dementia related hospitalisations (2.3%, 95% CI: 2.1-2.6%), weight loss/malnutrition (0.7%, 95% CI: 0.6-0.8%) and medication-related events (0.6%, 95% CI: 0.5-0.7%).
CONCLUSIONS: Twelve quality and safety indicators were developed to monitor aged care provided to older Australians based on the synthesis of existing literature and expert advisory input. These indicators rely on existing data within the aged care and healthcare sectors, therefore creating a pragmatic tool to examine quality and unwarranted care variation.
© The Author(s) 2020. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aged care; quality and safety indicators; quality improvement

Mesh:

Year:  2020        PMID: 32696038     DOI: 10.1093/intqhc/mzaa078

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  4 in total

1.  Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study.

Authors:  Janet K Sluggett; Gillian E Caughey; Tracy Air; Max Moldovan; Catherine Lang; Grant Martin; Stephen R Carter; Shane Jackson; Andrew C Stafford; Steve L Wesselingh; Maria C Inacio
Journal:  Age Ageing       Date:  2022-07-01       Impact factor: 12.782

2.  Cohort profile: Dementia in the Registry of Senior Australians.

Authors:  Monica Cations; Catherine E Lang; Stephanie A Ward; Maria Crotty; Craig Whitehead; John Maddison; Maria Inacio
Journal:  BMJ Open       Date:  2021-02-01       Impact factor: 2.692

Review 3.  Quality indicators for home- and community-based aged care: A critical literature review to inform policy directions.

Authors:  Hui Yuan Foong; Joyce Siette; Mikaela Jorgensen
Journal:  Australas J Ageing       Date:  2022-07-03       Impact factor: 1.876

4.  The risk of fall-related hospitalisations at entry into permanent residential aged care.

Authors:  Maria C Inacio; Max Moldovan; Craig Whitehead; Janet K Sluggett; Maria Crotty; Megan Corlis; Renuka Visvanathan; Steve Wesselingh; Gillian E Caughey
Journal:  BMC Geriatr       Date:  2021-12-07       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.